These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22012766)

  • 21. Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
    Shu GS; Yang ZL; Liu DC
    Pathol Res Pract; 2012 Jul; 208(7):392-7. PubMed ID: 22658478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma.
    Wang W; Yang ZL; Liu JQ; Yang LP; Yang XJ; Fu X
    Tumori; 2014; 100(6):667-74. PubMed ID: 25688501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRMS1 and HPA as Progression, Clinical Biological Behaviors, and Poor Prognosis-related Biomarkers for Gallbladder Adenocarcinoma.
    Yang Z; Liu F; Yang ZL
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):275-82. PubMed ID: 26200836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of annexin A1 (ANXA1) and A2 (ANXA2) and its significance in benign and malignant lesions of gallbladder].
    Yang LP; Yang ZL; Tan XG; Miao XY
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):595-9. PubMed ID: 21122411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
    Shu GS; Lv F; Yang ZL; Miao XY
    Int J Clin Oncol; 2013 Aug; 18(4):641-50. PubMed ID: 22714709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
    Yuan Y; Yang ZL; Zou Q; Li JH; Li DQ; Liang LF; Zeng GX; Chen SL
    Neoplasma; 2013; 60(6):698-705. PubMed ID: 23906305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
    Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
    J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
    Wu W; Pan C; Yu H; Gong H; Wang Y
    J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma.
    Kim HS; Kim GY; Lim SJ; Park YK; Kim YW
    Hum Pathol; 2010 Nov; 41(11):1609-16. PubMed ID: 20688353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder.
    Roa JC; Roa I; Correa P; Vo Q; Araya JC; Villaseca M; Guzmán P; Schneider BG
    J Gastroenterol; 2005 Jan; 40(1):79-86. PubMed ID: 15692793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.
    Dong Y; Bi LR; Xu N; Yang HM; Zhang HT; Ding Y; Shi AP; Fan ZM
    Pathol Res Pract; 2013 Sep; 209(9):555-61. PubMed ID: 23916993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expressions of cell junction regulatory proteins and their association with clinicopathologic parameters in benign and malignant gallbladder lesions.
    Xiong L; Wen Y; Miao X; Yang Z
    Am J Med Sci; 2011 Nov; 342(5):388-94. PubMed ID: 22033073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma.
    Leal P; García P; Sandoval A; Letelier P; Brebi P; Ili C; Álvarez H; Tapia O; Roa JC
    Arch Pathol Lab Med; 2013 Apr; 137(4):552-7. PubMed ID: 23544944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer.
    Avoranta ST; Korkeila EA; Ristamäki RH; Syrjänen KJ; Carpén OM; Pyrhönen SO; Sundström JT
    Hum Pathol; 2013 Jun; 44(6):966-74. PubMed ID: 23332924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma.
    Choi SY; Jo YS; Huang SM; Liang ZL; Min JK; Hong HJ; Kim JM
    Hum Pathol; 2011 Oct; 42(10):1476-83. PubMed ID: 21496863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications.
    Rahadiani N; Ikeda J; Mamat S; Matsuzaki S; Ueda Y; Umehara R; Tian T; Wang Y; Enomoto T; Kimura T; Aozasa K; Morii E
    Cancer Sci; 2011 Apr; 102(4):903-8. PubMed ID: 21231983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
    Vogler T; Kriegl L; Horst D; Engel J; Sagebiel S; Schäffauer AJ; Kirchner T; Jung A
    Exp Mol Pathol; 2012 Feb; 92(1):111-7. PubMed ID: 22101256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions.
    Xiong L; Deng X; Wen Y; Yang Z; Miao X
    World J Surg Oncol; 2013 Mar; 11():80. PubMed ID: 23531103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.
    Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z
    Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.